Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

The goal of this clinical study is to assess the efficacy and safety of LUPKYNIS® in combination with belimumab, obinutuzumab or anifrolumab at inducing rapid renal response in patients with lupus nephritis (LN).

Participants needed: 150
Trial details
Phase: Phase 4Age: 18-75Biological sex: AllType: InterventionalSponsor: Aurinia Pharmaceuticals Inc.Updated: Jun 12, 2026Locations: 15
Eligibility criteria

Adults 18-75 years old [+7]

Any B cell targeted therapy except for the concomitant biologics (belimumab and... [+7]

Read more
Status: Recruiting

Study of Aritinercept in Patients With Generalized Myasthenia Gravis

This clinical study will enroll patients with generalized myasthenia gravis (gMG). The goal of this clinical study is to assess the safety, tolerability, effectiveness, pharmacokinetics (how the body processes the drug) and pharmacodynamics (how the drug affects the body) of aritinercept.

Participants needed: 81
Trial details
Phase: Phase 1, Phase 2Age: 18-85Biological sex: AllType: InterventionalSponsor: Aurinia Pharmaceuticals Inc.Updated: May 19, 2026Locations: 3
Eligibility criteria

Adult patients (18-85 years old) [+2]

Current or medical history of malignancy within the last 5 years [+2]

Read more